# Perspectives of Subcutaneous Velcade at Home of Patients With Myeloma.

> **NCT05163405** · — · COMPLETED · sponsor: **Karin B. Ø. Dieperink** · enrollment: 10 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Bortezomib

## Key facts

- **NCT ID:** NCT05163405
- **Lead sponsor:** Karin B. Ø. Dieperink
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05163405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05163405, "Perspectives of Subcutaneous Velcade at Home of Patients With Myeloma.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05163405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*